Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmather Holdings Ltd
PHRRF
Primary Symbol:
C.PHRM
psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The...
Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 04, 2021 9:43am
$PHRM - Update ($$$$$)
https://stockhouse.com/news/press-releases/2021/02/04/pharmather-announces-successful-completion-of-pre-ind-meeting-with-fda-for-the
(493)
•••
Iconic25
X
View Profile
View Bullboard History
Post by
Iconic25
on Feb 04, 2021 8:44am
Magic Mushrooms
Sponsored post: "Magic Mushrooms" have long, slender stems which may appear white or greyish topped by caps with dark gills on the underside. Read this to understand about magic muchrooms,
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Feb 04, 2021 8:28am
PharmaTher To Commence Phase 2 Clinical Study On Ketamine In
Pharmather is successfully progressing on the development of its proposed phase 2 clinical study on ketamine in the use of levodopa-induced dyskinesia in patients with Parkinson’s disease. The company
...more
(37)
•••
amp007C
X
View Profile
View Bullboard History
Post by
amp007C
on Feb 04, 2021 8:23am
News
GLOBENEWSWIRE PharmaTher Announces Successful Completion of Pre-IND Meeting with FDA for the Clinical Development of Ketamine in the Treatment of Parkinson’s Disease 02/04/2021 8:00:00 AM
...more
(4)
•••
19LDS84
X
View Profile
View Bullboard History
Comment by
19LDS84
on Feb 03, 2021 9:57pm
RE:How much cash does the company have?
Yes very quite. Not sure why though. I feel like this company is way undervalued. Probably a good thing I suppose. They need some good PR. to get things moving
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Feb 03, 2021 7:03pm
$PHRM - Corporate Deck (Feb 2021)
https://www.pharmather.com/uploads/1/2/5/8/125844350/deck_-_phrm_-_1020201.pdf
(37)
•••
amp007C
X
View Profile
View Bullboard History
Post by
amp007C
on Feb 01, 2021 7:36pm
How much cash does the company have?
Anyone know? Quiet board.
(37)
•••
amp007C
X
View Profile
View Bullboard History
Comment by
amp007C
on Feb 01, 2021 12:47pm
RE:PharmaTher Licenses Patented Microneedle Delivery Tech For K
I'm quite happy about this, because it is easy to see what the company is doing. These aren't arbitrary moves, and they seem to have a firm grasp on what they want to accomplish. Happy to be a
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Feb 01, 2021 8:14am
PharmaTher Licenses Patented Microneedle Delivery Tech For K
PharmaTher this morning announced that it has entered into an exclusive worldwide patent and know-how license agreement with that of the The Queen’s University of Belfast. The arrangement pertains to
...more
(37)
•••
amp007C
X
View Profile
View Bullboard History
Post by
amp007C
on Feb 01, 2021 7:47am
Premarket looks great...
Still early, but the premarket is looking great so far. I'm hoping it stays this way, or goes even higher.
(37)
•••
amp007C
X
View Profile
View Bullboard History
Post by
amp007C
on Jan 28, 2021 1:22pm
I picked up some more at .365
Here's hoping that was the bottom of the barrel...
(37)
•••
amp007C
X
View Profile
View Bullboard History
Post by
amp007C
on Jan 27, 2021 9:23am
Premarket tanking
What the hell...
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Jan 22, 2021 11:10am
$RVV $RVVTF - ETF ($$$$$)
https://stockhouse.com/news/press-releases/2021/01/22/revive-therapeutics-included-in-first-psychedelic-exchange-traded-fund
(37)
•••
amp007C
X
View Profile
View Bullboard History
Comment by
amp007C
on Jan 21, 2021 10:19am
RE:$$RVV $RVVTF - Update ($$$$$)
Shouldn't this boost Phrm by contrast?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Drilling Approval Received for New Mexico Lithium Project
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service